Differences between the activities of human monoclonal IgG1 and IgG3 anti-D antibodies of the Rh blood group system in their abilities to mediate effector functions of monocytes.

Edith Wiener(St Mary's Hospital), N. C. Hughes‐Jones, M.D. Melamed, V. M. Jolliffe, K. M. Thompson, Belinda M. Kumpel(NHS Blood and Transplant), H. C. F. Scott

PubMed

October 1, 1988

Cited by 63

Related Papers

A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy

|Blood|2013|226

Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed B-lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity.

|PubMed|1994|107

Mechanism of anti-D-mediated immune suppression – a paradox awaiting resolution?

|Trends in Immunology|2001|103

Efficacy of RhD monoclonal antibodies in clinical trials as replacement therapy for prophylactic anti‐D immunoglobulin: more questions than answers

|Vox Sanguinis|2007|97

Human monoclonal anti‐D antibodies. I. THEIR PRODUCTION, SEROLOGY, QUANTITATION AND POTENTIAL USE AS BLOOD GROUPING REAGENTS

|British Journal of Haematology|1989|93